Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ONCE - Spark Therapeutics Inc.

Previous close
113.57
0   0%

Share volume: 0
Last Updated: Mon 16 Dec 2019 06:00:00 AM CET
Biotechnology: -0.99%

PREVIOUS CLOSE
CHG
CHG%
$113.57
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
15%
Profitability 0%
Dept financing 12%
Liquidity 40%
Performance 23%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$113.57
P/E Ratio 
N/A
DAY RANGE
$113.57 - $113.57
EPS 
-$6.54
52 WEEK RANGE
$34.53 - $114.20
52 WEEK CHANGE
$177.07
MARKET CAP 
4.287 B
YIELD 
N/A
SHARES OUTSTANDING 
37.747 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$34,804,395
AVERAGE 10 VOLUME 
$723,831
AVERAGE 30 VOLUME 
$492,451
Company detail
CEO:
Region: US
Website: http://www.sparktx.com
Employees: 368
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.

Recent news